Literature DB >> 27347206

Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population.

Haiyan Guo1, Shaodi Yang2, Lijian Xu3, Ding Li3, Jianxin Tang3, Shuangshaung Wang3, Benjie Wei4, Zhengchun Liu2.   

Abstract

As a member of the p53 gene family, the p73 gene can affect an individual's susceptibility to cancer through a p53-like manner. DNA sequence variation in the p73 gene has been reported to be associated with cancer risk. The present study aimed to identify whether the p73 gene G4C14-to-A4T14 single nucleotide polymorphism (SNP) is associated with risk of cervical cancer in a Chinese population. The p73 G4C14-to-A4T14 polymorphism was genotyped in 175 cervical cancer and 189 healthy control peripheral blood DNA samples using high resolution melting, polymerase chain reaction with confronting two-pair primers and direct DNA sequencing. The results demonstrated that carriers of the AT/AT genotype were associated with a significantly increased risk of cervical cancer (P=0.042; χ2=4.122; odds ratio = 2.241; 95% confidence interval = 1.013-4.956) compared with the GC/GC genotype carriers. In addition, there was a significant association between p73 genotypes and tumor size in patients with cervical cancer (P=0.014; χ2=8.607). However, no association was identified between p73 genotypes and tumor stage, histological type or lymph node metastasis in patients with cervical cancer. These results suggest that the p73 G4C14-to-A4T14 SNP may function as a marker of genetic susceptibility to cervical cancer in the Chinese population.

Entities:  

Keywords:  cervical cancer; high resolution melting; p73; polymerase chain reaction with confronting two-pair primer; polymorphism; susceptibility

Year:  2016        PMID: 27347206      PMCID: PMC4907279          DOI: 10.3892/ol.2016.4655

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  [Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].

Authors:  Peng Yuan; Xiao-ping Miao; Xue-mei Zhang; Zhong-hua Wang; Wen Tan; Xiang-ru Zhang; Yan Sun; Bing-he Xu; Dong-xin Lin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2006-02

2.  Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study.

Authors:  Xin Zhou; Chengyi Wu
Journal:  Med Oncol       Date:  2012-04-26       Impact factor: 3.064

3.  Unique microRNA expression profiles in cervical cancer.

Authors:  Katalin Gocze; Katalin Gombos; Krisztina Juhasz; Krisztina Kovacs; Bela Kajtar; Marta Benczik; Peter Gocze; Balazs Patczai; Istvan Arany; Istvan Ember
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

4.  The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies.

Authors:  Elya E Moore; John D Wark; John L Hopper; Bircan Erbas; Suzanne M Garland
Journal:  Twin Res Hum Genet       Date:  2012-02       Impact factor: 1.587

5.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

6.  Genetic association between p73 G4C14-A4T14 polymorphism and risk of squamous cell carcinoma.

Authors:  Shan Xia; Li Fang; Jing He; Zigang Zhao; Fang Xie; Hengjin Li
Journal:  Clin Exp Med       Date:  2014-12-17       Impact factor: 3.984

Review 7.  p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?

Authors:  Joanna Zawacka-Pankau; Anna Kostecka; Alicja Sznarkowska; Elisabeth Hedström; Anna Kawiak
Journal:  Cell Cycle       Date:  2010-02-16       Impact factor: 4.534

8.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12

Review 9.  The impact of p53 and p73 on aneuploidy and cancer.

Authors:  Richard Tomasini; Tak W Mak; Gerry Melino
Journal:  Trends Cell Biol       Date:  2008-04-10       Impact factor: 20.808

10.  Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.

Authors:  Shan Kang; Dong-Jie Wang; Wan-Sheng Li; Na Wang; Rong-Miao Zhou; Dong-Lan Sun; Ya-Nan Duan; Shi-Zhen Li; Xiao-Fei Li; Yan Li
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

View more
  4 in total

1.  Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and in vitro investigation.

Authors:  Rui Zhang; Peng Lin; Hong Yang; Yun He; Yi-Wu Dang; Zhen-Bo Feng; Gang Chen
Journal:  Oncotarget       Date:  2017-11-26

2.  Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis.

Authors:  Xianghua Liang; Bingxiang Chen; Jianxin Zhong
Journal:  Oncotarget       Date:  2017-05-24

3.  MiR-1180-5p regulates apoptosis of Wilms' tumor by targeting p73.

Authors:  Xiuyun Jiang; Huaicheng Li
Journal:  Onco Targets Ther       Date:  2018-02-16       Impact factor: 4.147

Review 4.  Dual Role of p73 in Cancer Microenvironment and DNA Damage Response.

Authors:  Julian M Rozenberg; Svetlana Zvereva; Alexandra Dalina; Igor Blatov; Ilya Zubarev; Daniil Luppov; Alexander Bessmertnyi; Alexander Romanishin; Lamak Alsoulaiman; Vadim Kumeiko; Alexander Kagansky; Gerry Melino; Nikolai A Barlev
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.